ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0038

The Role of Dual Specificity Phosphatase 22 (DUSP22) in Rheumatoid Arthritis: Mechanism and Genetic Investigations

Wei-Ting Hung1, Yi-Ming Chen2, Wen-Nan Huang3, Tsai-Hung Yen4, Tse-Hua Tan5 and Huai-Chia Chuang6, 1Taichung Veteran General Hospital, Taichung City, Taiwan (Republic of China), 2Taichung Veterans General Hospital, Taiwan, Taichung, Taiwan (Republic of China), 3Taichung Veterans General Hospital, Taichung, Taiwan, Taichung, Taiwan (Republic of China), 4Taichung Veterans General Hospital, Xitun District, Taichung City, Taiwan (Republic of China), 5National Health Research Institutes, Mao-Li, Taiwan (Republic of China), 6National Health Research Institutes, Zhunan, Taiwan (Republic of China)

Meeting: ACR Convergence 2024

Keywords: Cell-signalling molecules, immunology, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a debilitating autoimmune disorder characterized by chronic inflammation and joint damage. This study investigates the role of Dual Specificity Phosphatase 22 (DUSP22), also known as JKAP, in the pathogenesis of RA, with a specific focus on its interaction with UBR2 and the downstream effects on T cell activation. We also explore the hypothesis that single nucleotide polymorphisms (SNPs) within the UBR2 gene may lead to functional changes in the protein, affecting its role in the immune response and contributing to the variability in RA disease progression observed among patients.

Methods:  Peripheral blood samples were collected from 14 RA patients and 6 healthy controls. DUSP22 expression was analyzed using Western blotting. T cells were purified and activated, followed by proximity ligation assays (PLA) to assess Lck ubiquitination and UBR2-Lck interactions. JKAP knockout (KO) mice were generated to evaluate arthritis severity and cytokine profiles. Histological analyses and ELISAs were performed to assess joint damage and cytokine levels, respectively. Genotyping of the UBR2 gene in RA patients and healthy controls was conducted using next-generation sequencing to identify prevalent SNPs.

Results:  DUSP22 expression was significantly reduced in the peripheral blood leukocytes and T cells of RA patients compared to healthy controls. UBR2 is implicated in protein degradation pathways and interacts with key signaling molecules involved in immune cell activation, such as Lck. UBR2 modulates Lck activity through K63-linked ubiquitination, suggesting a critical role in T cell signaling and autoimmune disease pathogenesis. JKAP KO mice exhibited more severe arthritis with increased synovial proliferation and cartilage damage. Elevated levels of pro-inflammatory cytokines IL-6 and IL-17A were observed in the serum and joint tissues of JKAP KO mice. Genotyping revealed significant SNPs within the UBR2 gene, which may lead to functional changes in the protein and affect immune response variability, potentially contributing to RA disease progression.

Conclusion: Our findings suggest that DUSP22 plays a critical role in modulating inflammatory processes in RA. The downregulation of DUSP22 in RA patients may influence UBR2-mediated pathways, contributing to the heightened T cell activation and inflammation observed in RA. Additionally, SNPs within the UBR2 gene may lead to functional changes affecting immune response variability and RA disease progression. These results highlight DUSP22 and UBR2 as potential therapeutic targets for RA and provide insights into the molecular mechanisms underlying RA pathogenesis.


Disclosures: W. Hung: None; Y. Chen: None; W. Huang: None; T. Yen: None; T. Tan: None; H. Chuang: None.

To cite this abstract in AMA style:

Hung W, Chen Y, Huang W, Yen T, Tan T, Chuang H. The Role of Dual Specificity Phosphatase 22 (DUSP22) in Rheumatoid Arthritis: Mechanism and Genetic Investigations [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-role-of-dual-specificity-phosphatase-22-dusp22-in-rheumatoid-arthritis-mechanism-and-genetic-investigations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-dual-specificity-phosphatase-22-dusp22-in-rheumatoid-arthritis-mechanism-and-genetic-investigations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology